Logo

Nashville Biosciences

Illumina, Nashville Biosciences Ink WGS Agreement With Amgen for African American Cohort

As part of the agreement, Amgen subsidiary DeCode Genetics will perform WGS on 35,000 DNA samples from VUMC's biobank using Illumina platforms.

Genuity Science Gains Access to BioVU With Nashville Biosciences Deal

Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.

PMI Biopharma, Nashville Biosciences Form Drug Development Services Alliance

The companies have agreed to combine their respective offerings into a single services package for drug target identification and validation.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.